Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Kapadia Sandip Create: Alert

All | News | Filings
Date FiledTypeDescription
05/26/2023 4 Kapadia Sandip (Director) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 24,000 options to buy @ $1, valued at $24k
03/31/2023 4 Kapadia Sandip (CFO) has filed a Form 4 on Harmony Biosciences Holdings, Inc.
Txns: Paid exercise price by delivering 15,414 shares @ $33.36, valued at $514.2k
Exercised 30,000 restricted stock units @ $0
12/02/2022 4 Kapadia Sandip (Director) has filed a Form 4 on Passage BIO, Inc.
Txns: Sold 5,000 shares @ $1.1929, valued at $6k
05/31/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/28/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/31/2021 4 Kapadia Sandip (CFO) has filed a Form 4 on Harmony Biosciences Holdings, Inc.
Txns: Granted 60,000 restricted stock units @ $0
Granted 230,000 options @ $29.03, valued at $6.7M
01/26/2021 4 Kapadia Sandip (CFO and Treasurer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Granted 17,200 shares @ $0
Granted 26,900 options to buy @ $29.46, valued at $792.5k
01/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/16/2020 4 Kapadia Sandip (CFO and Treasurer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Sold 1,763 shares @ $32.78, valued at $57.8k
10/05/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/03/2020 4 Kapadia Sandip (CFO and Treasurer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 615 shares @ $58.4, valued at $35.9k
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/27/2020 4 Kapadia Sandip (CFO and Treasurer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Granted 5,600 shares @ $0
Granted 9,200 options to buy @ $99.66, valued at $916.9k
01/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/03/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2019 4 Kapadia Sandip (CFO and Treasurer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 615 shares @ $79.17, valued at $48.7k
04/03/2019 4 Kapadia Sandip (CFO and Treasurer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 615 shares @ $111.5, valued at $68.6k
01/18/2019 4 Kapadia Sandip (CFO and Treasurer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Granted 4,500 shares @ $0
Granted 7,200 options to buy @ $110.8, valued at $797.8k
01/03/2019 4 Kapadia Sandip (CFO and Treasurer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 1,118 shares @ $100.79, valued at $112.7k
10/03/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/22/2018 4 Kapadia Sandip (CFO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC
Txns: Granted 6,900 shares @ $0
Granted 10,500 options to buy @ $58.74, valued at $616.8k
10/04/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/03/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
07/06/2016 4 Kapadia Sandip (CFO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC
Txns: Granted 15,000 shares @ $0
Granted 18,000 options to buy @ $146.36, valued at $2.6M

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy